tiprankstipranks
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
US Market

Cumberland Pharmaceuticals (CPIX) Stock Price & Analysis

173 Followers

CPIX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.43 - $2.36
Previous Close$1.71
Volume11.82K
Average Volume (3M)12.61K
Market Cap
$24.24M
Enterprise Value$24.01M
Total Cash (Recent Filing)$18.32M
Total Debt (Recent Filing)$18.43M
Price to Earnings (P/E)-3.8
Beta0.27
May 07, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding14,255,700
10 Day Avg. Volume13,341
30 Day Avg. Volume12,605
Standard Deviation0.15
R-Squared0.00439
Alpha-0.00689
Financial Highlights & Ratios
Price to Book (P/B)4.01
Price to Sales (P/S)2.61
Price to Cash Flow (P/CF)5.90
P/FCF Ratio5.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.61
Enterprise Value/Gross Profit0.72
Enterprise Value/Ebitda142.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

46.31%7.45%5.35%40.89%
46.31% Insiders
5.35% Other Institutional Investors
40.89% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

CPIX FAQ

What was Cumberland Pharmaceuticals Inc’s price range in the past 12 months?
Cumberland Pharmaceuticals Inc lowest stock price was $1.43 and its highest was $2.36 in the past 12 months.
    What is Cumberland Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is Cumberland Pharmaceuticals Inc’s upcoming earnings report date?
    Cumberland Pharmaceuticals Inc’s upcoming earnings report date is May 07, 2024 which is in 40 days.
      How were Cumberland Pharmaceuticals Inc’s earnings last quarter?
      Cumberland Pharmaceuticals Inc released its earnings results on Mar 05, 2024. The company reported -$0.444 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.444.
        Is Cumberland Pharmaceuticals Inc overvalued?
        According to Wall Street analysts Cumberland Pharmaceuticals Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cumberland Pharmaceuticals Inc pay dividends?
          Cumberland Pharmaceuticals Inc does not currently pay dividends.
          What is Cumberland Pharmaceuticals Inc’s EPS estimate?
          Cumberland Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Cumberland Pharmaceuticals Inc have?
          Cumberland Pharmaceuticals Inc has 14,176,529 shares outstanding.
            What happened to Cumberland Pharmaceuticals Inc’s price movement after its last earnings report?
            Cumberland Pharmaceuticals Inc reported an EPS of -$0.444 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3%.
              Which hedge fund is a major shareholder of Cumberland Pharmaceuticals Inc?
              Among the largest hedge funds holding Cumberland Pharmaceuticals Inc’s share is Ariel Investments LLC. It holds Cumberland Pharmaceuticals Inc’s shares valued at N/A.
                ---

                Cumberland Pharmaceuticals Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                -13.19%
                12-Months-Change

                Fundamentals

                Return on Equity
                -19.06%
                Trailing 12-Months
                Asset Growth
                -12.00%
                Trailing 12-Months

                Company Description

                Cumberland Pharmaceuticals Inc

                Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Hepatoren, Vaprisol, Boxaban, Vasculan, Ethyol, Portaban, and Totect. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Perrigo Company
                Petmed Express
                AC Immune SA
                Aldeyra Therapeutics
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis